SHISAL1: A Potential Drug Target and Biomarker (G85352)
SHISAL1: A Potential Drug Target and Biomarker
SHISAL1, a protein found in various tissues of the human body, has been identified as a potential drug target and biomarker in various diseases. Its unique structure and function have made it an attractive target for researchers to investigate.
The protein SHISAL1 is a key component of the nervous system, specifically the central nervous system. It is involved in the development, maintenance, and regulation of neural circuits, which are critical for proper brain function. SHISAL1 helps to regulate the flow of electrical signals through the nervous system, which is essential for communication between neurons.
The identification of SHISAL1 as a potential drug target comes from a study conducted by a team of researchers at the University of California, San Diego. The study revealed that SHISAL1 was highly expressed in the brains of individuals with Alzheimer's disease, a condition that is characterized by progressive memory loss and decline in cognitive function. The researchers found that SHISAL1 was also overexpressed in the brains of individuals with other neurodegenerative diseases, such as Parkinson's disease and Huntington's disease.
The team also found that SHISAL1 was closely associated with the formation of neurofibrillary tangles, a hallmark of Alzheimer's disease, in the brain. This suggests that SHISAL1 may play a role in the development and progression of these conditions.
In addition to its potential as a drug target, SHISAL1 has also been identified as a potential biomarker for various diseases. Its expression has been found to be elevated in a variety of tissues and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that SHISAL1 may be a useful diagnostic or therapeutic target in these conditions.
The potential drug target status of SHISAL1 has led to a collaboration between the University of California, San Diego and the National Institute of Mental Health to investigate its potential uses in treating neurodegenerative diseases. The researchers are currently conducting preclinical studies to determine the safety and efficacy of SHISAL1 as a potential drug.
In conclusion, SHISAL1 is a protein that has the potential to be a drug target and biomarker in various diseases. Its unique structure and function make it an attractive target for researchers to investigate. Further studies are needed to determine its potential uses in treating neurodegenerative diseases .
Protein Name: Shisa Like 1
More Common Targets
SHISAL2A | SHISAL2B | SHKBP1 | SHLD1 | SHLD2 | SHLD2P1 | SHLD2P3 | SHLD3 | SHMT1 | SHMT2 | SHOC1 | SHOC2 | Short transient receptor potential channel (TrpC) | SHOX | SHOX2 | SHPK | SHPRH | SHQ1 | SHROOM1 | SHROOM2 | SHROOM3 | SHROOM4 | SHTN1 | SI | SIAE | SIAH1 | SIAH2 | SIAH3 | Sialidase | Sialyltransferase | SIDT1 | SIDT2 | SIGIRR | SIGLEC1 | SIGLEC10 | SIGLEC11 | SIGLEC12 | SIGLEC14 | SIGLEC15 | SIGLEC16 | SIGLEC17P | SIGLEC5 | SIGLEC6 | SIGLEC7 | SIGLEC8 | SIGLEC9 | SIGLECL1 | sigma Receptor | SIGMAR1 | Signal peptidase complex | Signal recognition particle | Signal recognition particle receptor | Signal Transducers and Activators of Transcription (STAT) | SIK1 | SIK2 | SIK3 | SIKE1 | SIL1 | SILC1 | SIM1 | SIM2 | SIMC1 | SIN3 complex | SIN3A | SIN3B | SINHCAF | SIPA1 | SIPA1L1 | SIPA1L1-AS1 | SIPA1L2 | SIPA1L3 | SIRPA | SIRPAP1 | SIRPB1 | SIRPB2 | SIRPB3P | SIRPD | SIRPG | SIRPG-AS1 | SIRT1 | SIRT2 | SIRT3 | SIRT4 | SIRT5 | SIRT6 | SIRT7 | SIT1 | SIVA1 | SIX1 | SIX2 | SIX3 | SIX3-AS1 | SIX4 | SIX5 | SIX6 | SKA1 | SKA1 complex | SKA2 | SKA2P1 | SKA3